Login/Register 
United States ($) USD
Austria (€) EUR
Belgium (€) EUR
Finland (€) EUR
France (€) EUR
Germany (€) EUR
Ireland (€) EUR
Japan (¥) JPY
Luxembourg (€) EUR
Netherlands (€) EUR
Switzerland (CHF) CHF
United Kingdom (£) GBP
Stimulation With a Superagonistic Anti-CD28 Antibody Shows Treg Expansion
Description: Rebecca Nickle, PhD, of BioLegend discusses how our antibody clone, S20013B, affects T cell and Treg development via analysis in flow cytometry, multiomics, cell culturing, and LEGENDplex™ immunoassay experiments.
Follow Us